Tablet Preparation
Tablet Preparation - Related Videos
11:11
Preparing and Administering Oral Tablet and Liquid Medications
0 Views •
2015
Source: Madeline Lassche, MSNEd, RN and Katie Baraki, MSN, RN, College of Nursing, University of Utah, UT Oral medications are the route most preferred by patients and are one of the most commonly used routes of medication administration by providers. Most oral preparations are taken by mouth, swallowed with fluid, and absorbed via the gastrointestinal tract. Oral medications are available in solid forms (e.g., tablets, capsules, caplets, and enteric-coated tablets) and liquid forms (e.g.,...
10:13
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
0 Views •
Cited by 11 •
2014
We tested the usability of a tablet-computer-based application (EmoCogMeter) in investigating the effects of age on cognition. Results show an age-related cognitive decline, thereby proving the usability of our application. Findings underline the great clinical and practical potential of a tablet-based application for detection and monitoring of cognitive dysfunction.
10:10
Evaluating Tests of Cognition using a Computerized Touch-Sensitive Tablet, Eye Tracking, and Functional Magnetic Resonance Imaging
0 Views •
2026
A protocol for simultaneous recording of visuomotor behavior and brain activity during standard paper-based cognitive tests using an MRI-compatible tablet and eye-tracking technology alongside functional MRI, towards improving the usage of such tests. Preliminary results are presented from a young healthy adult performing a Trail-Making test.
05:44
Formation of Dispersible Taohong Siwu Tablets
0 Views •
2023
This article discusses the process used to formulate and prepare Taohong Siwu, a traditional Chinese medicine, as a dispersible tablet. We performed single-factor and orthogonal experiments to screen the prescription excipients, optimize the formulation process, and produce dispersible Taohong Siwu tablets.
01:18
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
0 Views •
2025
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
FAQs
Each excipient supports a different formulation requirement. Binders help the powder or granules form a coherent compact, while diluents contribute volume. Disintegrants promote tablet breakup after ingestion, and lubricants support the compaction process. Their combined use must preserve tablet strength while allowing suitable disintegration and dissolution, which directly affects drug availability.
Compaction pressure influences the balance between mechanical strength and drug release. Insufficient control can produce tablets that lack adequate strength, whereas excessive or unsuitable pressure may affect disintegration and dissolution. Maintaining controlled conditions helps produce tablets that remain intact during handling yet release the active ingredient appropriately after oral administration.
Direct compression compacts a blended formulation without identifying an intermediate granulation stage, whereas granulation introduces a granule-based route before compaction. The choice therefore changes how the formulation is prepared before pressure is applied. Both approaches must ultimately support consistent tablets with suitable strength, disintegration, dissolution, and dose uniformity.
These tests examine different aspects of tablet quality. Uniformity assesses consistency among doses, hardness indicates mechanical strength, and friability evaluates resistance to breaking or surface loss. Dissolution examines how the active ingredient becomes available from the tablet. Together, the results help determine whether production is consistent and likely to provide reproducible therapeutic performance.
A controlled workflow begins with blending the active ingredient and selected excipients, followed when applicable by granulation, then compaction into tablets. The finished units undergo testing for uniformity, hardness, friability, and dissolution. Controlling both processing and evaluation helps connect the formulation stage with reliable dosage performance in clinical care.
Clinical treatment depends on patients receiving consistent amounts of active ingredient in a form that performs predictably after ingestion. Tablet preparation supports this goal by combining accurate dosing with controlled mechanical properties and drug release behavior. Quality testing identifies whether the finished product meets these expectations, helping maintain stable therapeutic performance across produced tablets.